Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption

Yue Xu , Xiuying Xiao , Chunxiao Ma , Ziyi Wang , Wenxin Feng , Hanyu Rao , Wei Zhang , Ningyuan Liu , Rebiguli Aji , Xiangjun Meng , Wei-Qiang Gao , Li Li

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (12) : e70128

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (12) : e70128 DOI: 10.1002/ctm2.70128
RESEARCH ARTICLE

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption

Author information +
History +
PDF

Abstract

•In this study, we investigated the role of the histone methyltransferase NSD2 in preventing intestinal barrier disruption by sustaining taurine biosynthesis. NSD2 levels were reduced in both human specimens and mouse models of IBD. We demonstrate that NSD2 loss hinders the process of taurine synthesis in intestinal cells, leading to increased intestinal inflammation.

•Supplementation with taurine significantly relieved the symptoms caused by NSD2 deficiency. These data suggest that maintenance of NSD2-mediated taurine biosynthesis is vital for preserving the intestinal barrier and attenuating inflammation.

Keywords

histone methylation / IBD / intestinal epithelial homeostasis / NSD2 / taurine biosynthesis

Cite this article

Download citation ▾
Yue Xu,Xiuying Xiao,Chunxiao Ma,Ziyi Wang,Wenxin Feng,Hanyu Rao,Wei Zhang,Ningyuan Liu,Rebiguli Aji,Xiangjun Meng,Wei-Qiang Gao,Li Li. Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption. Clinical and Translational Medicine, 2024, 14(12): e70128 DOI:10.1002/ctm2.70128

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

89

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/